COPP, Free Sale Certificate, GMP Certificate & COA: Export Documents Explained
What each core pharmaceutical export document proves, who issues it, when importers and regulators ask for it, and how to avoid the document gaps that delay product registration and shipments.
Importers, distributors and health authorities rarely evaluate a pharmaceutical product on its dossier alone. Alongside the technical file, they ask for a small set of supporting certificates: the Certificate of Pharmaceutical Product (COPP), the Free Sale Certificate (FSC), the GMP certificate of the manufacturing site, and a Certificate of Analysis (COA) for each batch. These documents are often confused with each other, yet each answers a different question. Understanding what each one proves, who issues it and when it is needed helps buyers plan registrations and shipments without avoidable delays.
Why Supporting Certificates Matter
A dossier describes the product: its composition, manufacturing process, specifications, stability and labelling. Supporting certificates confirm facts about the product and the manufacturer that the importing authority cannot verify on its own.
They answer questions such as: Is this product authorised in the country where it is made? Is the factory inspected and compliant with Good Manufacturing Practice? Does this specific batch meet its specification?
Missing, expired or inconsistent certificates are among the most common reasons a registration file is queried or a consignment is held at the port. Planning for them early saves weeks.
Certificate of Pharmaceutical Product (COPP)
The COPP follows the format of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce. It is issued by the competent regulatory authority of the exporting country, not by the manufacturer.
A COPP typically confirms the product name and composition, whether the product is licensed for sale in the exporting country, the manufacturer and site details, and whether the site is subject to periodic GMP inspection.
Many importing authorities ask for a COPP as part of a new product registration. Some require it to be legalised or apostilled, and some require it to be issued specifically for their country. Buyers should check the importing authority's current requirements before the certificate is requested, because re-issuing it takes time.
Free Sale Certificate (FSC)
A Free Sale Certificate states that the product is freely sold, or is permitted to be sold, in the country of origin. It is also issued by the exporting country's authority.
Some markets accept a COPP in place of an FSC because the COPP already covers marketing status. Others ask for both, particularly for tenders or for product categories they classify differently.
Because an FSC usually lists specific products, it should match the product names, strengths and dosage forms in the dossier exactly. Small inconsistencies, such as a different strength format or brand name, are a frequent cause of queries.
GMP Certificate of the Manufacturing Site
A GMP certificate confirms that the manufacturing site has been inspected and found compliant with Good Manufacturing Practice for the listed dosage forms. In India, WHO-GMP certification for export is granted following inspection by the regulatory authorities.
Importers should check that the certificate covers the right site address and the right dosage forms (for example tablets, capsules or oral liquids), and that it is valid on the date of submission.
Some importing authorities also carry out their own inspection of the foreign site, or rely on inspections by recognised reference authorities. The GMP certificate is the starting point for that assessment.
Certificate of Analysis (COA)
A COA is issued by the manufacturer's quality control department for a specific batch. It lists each test in the finished product specification, the acceptance criteria and the actual result for that batch.
Unlike the COPP, FSC and GMP certificate, which relate to the product or site, the COA relates to one batch. A new COA accompanies every shipment, and importers often compare it against the registered specification on arrival.
Buyers should make sure the specification on the COA matches the one in the registered dossier, including the pharmacopoeia edition referenced, and that the batch number and expiry date match the shipping documents and labels.
Quick Comparison
The table below summarises what each document covers:
- COPP: Covers the product and its marketing status. Issued by the exporting country's regulator. Mainly used for product registration.
- Free Sale Certificate: Covers whether the product is sold in the country of origin. Issued by the exporting country's authority. Used for registration and some tenders.
- GMP Certificate: Covers the manufacturing site and dosage forms. Issued after regulatory inspection. Used for registration and supplier qualification.
- Certificate of Analysis: Covers a single batch. Issued by the manufacturer's QC laboratory. Used for every commercial shipment.
Practical Tips to Avoid Delays
Most document delays come from mismatches rather than missing certificates. A short checklist helps:
- Confirm the importing authority's current list of required certificates and whether legalisation or apostille is needed.
- Make sure product names, strengths and dosage forms are written identically across the COPP, FSC, dossier, artwork and invoice.
- Check certificate validity dates against your planned submission date, not just today's date.
- Keep the GMP certificate and site master file aligned with the site address shown on the COPP.
- Ask for a sample COA early so the specification can be compared with local pharmacopoeial requirements.
How Zelnex Supports Documentation
Zelnex Pharmaceuticals supplies WHO-GMP manufactured formulations with CTD/eCTD dossier support for international registration. When you request a quote, share your target market and the documents your importing authority requires, and our regulatory desk will confirm what can be provided for each product.
Browse the product catalogue on our Products page, review our regulatory and manufacturing capabilities on the Services page, or contact the export desk to request a quotation. If stability data is part of your registration, see our guide to Zone IVb stability testing.
More Technical Regulatory Insights
Understanding CTD & eCTD for Pharmaceutical Market Registration
A complete guide to Common Technical Document (CTD) and electronic CTD (eCTD) structures, Module 1–5 organization, and international regulatory registration strategies.
WHO-GMP in Pharmaceutical Manufacturing: What Buyers Should Know
Essential insights into Good Manufacturing Practice (GMP), quality systems, analytical controls, documentation audits, and evaluating pharmaceutical manufacturing partners.
